Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NICHICON, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 13%
6996 NICHICON CORPORATION 【J-GAAP】
Earnings ReportNICHICON CORPORATION <6996> [TSE Prime] announced its financial results after the market closed on February 6th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) decreased 12.9% from the same period last year to 5.46 billion yen. However, Progress toward the full-year plan of 7.00 billion yen was 78.1%, also surpassing the five-year average of 74.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to grow 23.8% from the same period last year, reaching 1.53 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit amounted to 3.11 billion yen, a 1.8% decrease compared to the same period last year. However, the operating profit margin improved from 4.2% in the same period last year to 5.3%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 138,751 | 7,946 | 9,770 | 8,005 | 117.0 | 85.6 | Feb 9, 2024 | J-GAAP |
| Apr - Dec, 2024 | 132,745 | 3,762 | 6,271 | 7,157 | 104.6 | 83.5 | Feb 6, 2025 | J-GAAP |
| Apr - Dec, 2025 | 124,254 | 3,851 | 5,465 | 4,019 | 59.9 | 78.1 | Feb 6, 2026 | J-GAAP |
| YoY | -6.4% | +2.4% | -12.9% | -43.8% | -42.8% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 91,244 | 3,446 | 4,409 | 1,816 | 26.6 | 18 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 99,268 | 4,459 | 4,647 | 4,380 | 65.2 | 18 | Nov 5, 2025 | J-GAAP |
| YoY | +8.8% | +29.4% | +5.4% | +141.2% | +145.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 181,643 | 8,904 | 11,407 | 8,253 | 120.6 | 33 | May 9, 2024 | J-GAAP |
| Mar, 2025 | 175,751 | 5,203 | 7,511 | 5,877 | 86.0 | 35 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 180,000 | 6,000 | 7,000 | 6,000 | 89.3 | 36 | May 9, 2025 | J-GAAP |
| YoY | +2.4% | +15.3% | -6.8% | +2.1% | +3.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 48,238 | 2,005 | 3,169 | 3,096 | 45.3 | 4.2 | Feb 6, 2025 | J-GAAP |
| Jan - Mar, 2025 | 43,006 | 1,441 | 1,240 | -1,280 | -18.7 | 3.4 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 39,601 | 724 | 1,050 | 1,187 | 17.7 | 1.8 | Aug 5, 2025 | J-GAAP |
| Jul - Sep, 2025 | 41,131 | 817 | 1,303 | 433 | 6.5 | 2.0 | Nov 5, 2025 | J-GAAP |
| Oct - Dec, 2025 | 43,522 | 2,310 | 3,112 | 2,399 | 35.7 | 5.3 | Feb 6, 2026 | J-GAAP |
| YoY | -9.8% | +15.2% | -1.8% | -22.5% | -21.1% |
Related Articles
SUGAI CHEMICAL, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 62%, Oct-Dec Ordinary Profit Turns to Loss
Yushiro Chemical, Oct-Dec (3Q) Ordinary Profit Increases by 3%
SHOEI YAKUHIN, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 14%
IDEC, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 2.1 times, Oct-Dec Ordinary Profit Increases by 2.2 times
J-OIL MILLS, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 52%, Oct-Dec Ordinary Profit Decreases by 55%
TAKAMISAWA, First Half Ordinary Profit Decreases by 28%, Oct-Dec Ordinary Profit Decreases by 17%
SAPPORO CLINICAL LAB, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Decreases by 9%
SEKI, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Loss, Oct-Dec Ordinary Profit Decreases by 42%
CL Holdings, Net Income Forecast for Last Fiscal Year Revised Upward by 12%, Dividend Revised Upward by 2 Yen
MT GENEX, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 25%, Oct-Dec Ordinary Profit Increases by 93%